@normahorn it's the same studies done already and 5 years of Evenity on the market has not, to my knowledge, revealed major CV problems. I have no idea why they expanded the content.

As a patient who has used it and may use it again, I would be interested in anything you see that is substantive that indicates increased CV risk. Are you able to find out why Australia did this change?

I cannot agree or disagree without more info.